Atomwise uses Deep Learning Neural Networks to help discover new medicines. Atomwise achieves the world’s best results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, startups, and research institutions. The Company's tools can tell the difference between great drug candidates and toxic ones, and discover new uses for old medicines.
|HQ||San Francisco, US||Map|
|Employees (est.) (Feb 2019)||33||(+7%)|
Atomwise total Funding
Atomwise latest funding size
Time since last funding
|a year ago|
|OS Fund, Grand Challenges Canada, Monsanto Growth Ventures (MGV), Khosla Ventures, B Capital Group, Data Collective, AME Cloud Ventures, Draper Fisher Jurvetson (DFJ), Baidu Ventures, Mission and Market, Tencent Holdings, DFJ Growth, Draper Associates, Farzad (Zod) Nazem, Y Combinator, Dolby Family Ventures|
Atomwise has 926 Twitter Followers. The number of followers has increased 3.6% month over month and increased 9.2% quarter over quarter
When was Atomwise founded?
Atomwise was founded in 2012.
Who are Atomwise key executives?
Atomwise's key executives are Bastiaan Bergman, Han Lim and Michael Mysinger.
How many employees does Atomwise have?
Atomwise has 33 employees.
Who are Atomwise competitors?
Competitors of Atomwise include BioXcel Therapeutics, Perrigo and Horizon Pharma.
Where are Atomwise offices?
Atomwise has an office in San Francisco.
How many offices does Atomwise have?
Atomwise has 1 office.